SANTA MONICA, Calif., March 22, 2017 /PRNewswire/ -- UBM and the Massachusetts Medical Device Industry Council (MassMEDIC) are proud to announce their extended partnership and the third annual Massachusetts Medtech Week. Massachusetts Medtech Week will be headlined by the 21st Annual MassMEDIC Conference held in conjunction with UBM's BIOMEDevice Boston, taking place May 3-4, 2017.
MassMEDIC will feature a conversation with Advanced Medical Technology Association (ADVAMED) President and CEO, Scott Whitaker, at its Annual Conference on May 3, 12:00 p.m. local time.
To learn more about BIOMEDevice Boston and the annual MassMEDIC Conference, please visit: biomedevice.mddionline.com
"We are thrilled to continue and strengthen our outstanding partnership with MassMEDIC and present the third annual Massachusetts Medtech Week," said Nina Brown, Vice President of Events, UBM. "UBM's continued partnership with MassMEDIC has allowed us to provide unmatched educational content and one of the largest forums for networking in the industry. We plan to continue on our past success and hone our events to drive the prosperous medical technology industry within the New England region forward."
Massachusetts Medtech Week brings together two of the region's most respected medical technology authorities to provide top-notch educational content featuring the latest innovations in medical technology. The device industry includes 480 companies with about 24,000 employees in Massachusetts, according to MassMEDIC*. New England's robust medical technology industry provides a diverse landscape that can be seen at the partnered events in May. The May event will draw more than 4,000 engineers and executives, house over 400 leading suppliers, and provide unmatched presentations and panel discussions.
"The partnership MassMEDIC has with UBM has been extremely beneficial to the medical technology industry in the New England region. We are honored to have our annual MassMEDIC conference once again headline Massachusetts Medtech week in conjunction with BIOMEDevice Boston," said Tom Sommer, President, MassMEDIC. "We are also proud to welcome ADVAMED President and CEO Scott Whitaker to our Annual Conference. ADVAMED is the voice for the medical technology industry and we are excited to have Whitaker provide insights from years of experience at our conference in May."
ADVAMED, the world's largest medical technology association, named Whitaker as its President and CEO in 2016. Whitaker is the voice of the medical technology industry and is recognized as a leading healthcare advocate and policy expert. Prior to taking leadership at ADVAMED, Whitaker was the Chief Operating Officer of the Biotechnology Innovation Organization (BIO) and also Chief of Staff of the United States Department of Health & Human Services (HHS).
Whitaker will be taking part in a "fireside chat" with Brian Johnson, editor of MassDevice, on how the policies of the Trump Administration will impact the medtech industry and the current climate of medtech innovation. To learn more about the keynote presentation, please visit: massmedic.com/events/annual-conference-2017
Event attendees will not only gain access to BIOMEDevice Boston and the 21st Annual MassMEDIC conference but also UBM's entire Advanced Design and Manufacturing event in Boston, featuring three additional expos under the same roof, including Design & Manufacturing (D&M) New England, Embedded Systems Conference (ESC) Boston, and PLASTEC New England.
UBM's Advanced Design and Manufacturing event in Boston continues to grow with the support of key sponsors, partners, exhibitors, and suppliers including: 3M, Allied Electronics, Auer Precision, The Davies Companies, Jordi Labs, Massachusetts Life Sciences Center, Massachusetts Medical Device Development Center (M2D2), and MedTech, Proto Labs, Tekscan, Toxikon, Turck.
To register for BIOMEDevice Boston and save on early bird pricing before March 31, please visit: boston.am.ubm.com/2017/registrations/BIOMED
To register for MassMEDIC's Annual Conference, please visit: massmedic.com/events/annual-conference-2017
About Advanced Manufacturing Expos & Conferences
UBM's Advanced Manufacturing portfolio is the leading B-to-B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the advanced manufacturing market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Advanced Manufacturing portfolio is organized by UBM plc. UBM is the largest pure-play B2B Events organizer in the world. Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors. Our deep knowledge and passion for these sectors allow us to create valuable experiences which enable our customers to succeed. Please visit www.ubm.com for the latest news and information about UBM.
UBM plc is the largest pure-play B2B Events organizer in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses. Our 3,750+ people, based in more than 20 countries, serve more than 50 different sectors – from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions. For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM, UBM Plc LinkedIn
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ubm-and-massachusetts-medical-device-industry-council-massmedic-partner-for-third-annual-massachusetts-medtech-week-300427512.html
SOURCE UBM Americas